Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Cuts PT and Estimates on Dendreon (DNDN); Going Off the Rails on a Crazy Train
-
Canaccord Genuity Maintains a 'Buy' on Hologic (HOLX); Looking for a Dip
-
Canaccord Genuity reiterates a 'Buy' on Herbalife (HLF); Currency and China Concerns Dismissed
-
Canaccord Genuity Upgrades USANA Health Sciences Inc. (USNA) to Buy; Two Main Concerns Alleviated
-
Streetinsider.com's Hot Lunchtime Reads 07/30: (GM) (PEET) (GT) (AAPL) (AXL) (UNG)
-
Canaccord Genuity Morning Coffee on Goodyear Tire (GT) and Cooper Tire & Rubber (CTB): Gaining Traction
-
Canaccord Genuity Morning Coffee on Portfolio Strategy: More Fireworks Next Week?
-
Notable Analyst Rating Changes 07/30: (DNDN) (PSX) (CHS) Upgraded; (JPM) (LLY) (EQIX) Downgraded
-
Canaccord Genuity on Biomedical Devices/Services: Q2 LVAD Survey Results In-line; Q3 Looks Robust
-
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); Migalastat Ph3 Data Preview
-
Canaccord Genuity Maintains a 'Hold' on First Solar (FSLR); N-T Results Not a Concern, Risk Remains L-T Growth
-
Canaccord Genuity Maintains a 'Hold' on Canadian Solar (CSIQ); Is There Still A Short Play Here?
-
Canaccord Genuity Maintains a 'Hold' on Digital Realty Trust (DLR); Confusion in Leasing Data
-
Canaccord Genuity Reiterates a 'Buy' on NQ Mobile (NQ); Raising Estimates on NationSky Acquisition
-
Canaccord Genuity Starts Cirrus Logic (CRUS) at Buy; Accumulate Shares Ahead of Earnings Report
-
Canaccord Genuity Upgrades Helmerich & Payne (HP) to Buy
-
Houston American Energy (HUSA) Taps Canaccord Genuity as Strategic Advisor
-
Canaccord Genuity Maintains a 'Buy' on Watson Pharmaceuticals (WPI); Post Q2: Solid Growth with Less Controversy
-
Canaccord Genuity Maintains a 'Hold' on United Therapeutics (UTHR); Increasing FY12 Adcirca and Tyvaso Revenues
-
Canaccord Genuity Reiterates a 'Buy' on Solta Medical (SLTM); LipoSonix Drives in Strong Q2
-
Canaccord Genuity Maintains a 'Hold' on Mylan (MYL); Raising PT on Solid Q2
-
Canaccord Genuity Reiterates a 'Buy' on Amarin Corp (AMRN); Vascepa Approved, Focus Shifts to BD
-
Canaccord Genuity Raises Price Target on Abaxis Inc. (ABAX); Vet Performing Well
-
Canaccord Genuity Maintains a 'Sell' on Veeco Instruments (VECO); Outperformance in a Weak Sector
-
Canaccord Genuity Raises Estimates on Nu Skin Enterprises (NUS); Lookin' Good
-
Canaccord Genuity Maintains a 'Hold' on Columbia Sportswear (COLM); Expects Inventory Rightsize By Year-End
-
Canaccord Genuity Cuts Price Target on Deckers Outdoor (DECK); Things Could Get UGGly
-
Canaccord Genuity Maintains a 'Hold' on Sprint (S); Not Calling It A Victory Just Yet
-
Canaccord Genuity Maintains a 'Hold' on MetroPCS (PCS); Changes to Credit Terms?
-
Canaccord Genuity Maintains a 'Buy' on Crown Castle (CCI); Benefit the Most from Strong Secular Tailwinds
-
Canaccord Genuity Maintains a 'Hold' on Amazon.com (AMZN); The Metamorphosis Continues
-
Canaccord Genuity Reiterates a 'Buy' on Datalink Corp (DTLK); Premium Partnership
-
Canaccord Genuity Maintains a 'Hold' on SPS Commerce (SPSC); Waiting For More Favorable Entry Point
-
Canaccord Genuity Maintains a 'Buy' on Constant Contact (CTCT); In Favor, But Still Have Something To Prove
-
Canaccord Genuity Maintains a 'Hold' on NetSuite (N); Solid Quarter, But Valuation High
-
Canaccord Cuts Target on Patterson-UTI (PTEN) to $21, Maintains Buy
-
Canaccord Genuity on Zynga (ZNGA): Next stop: Disasterville
-
UPDATE: Canaccord Genuity Downgrades Meridian Biosciences (VIVO) to Hold; Changing Investment Thesis
-
Canaccord Genuity Portfolio Strategy: Half Way to Half Way
-
Canaccord Genuity on S&P 500: Waterboarding vs. Chinese Water Torture
-
Canaccord Genuity Reiterates a 'Buy' on Quidel Corp. (QDEL); Focus Now on New Products
-
Canaccord Genuity Maintains a 'Buy' on NuVasive (NUVA); Q2 Review
-
Canaccord Genuity Lower PT & Estimates on Greatbatch, Inc. (GB); In-line Q2; Stagnant Operating Margin
-
Canaccord Genuity Raises Estimates on Alexion Pharmaceuticals (ALXN); Pleased with aHUS Launch Progress
-
Canaccord Genuity Maintains a 'Buy' on Headwaters (HW); Q3 Preview: Remain Encouraged About 2H Trends
-
Canaccord Genuity Maintains a 'Buy' on Crown Castle (CCI); Q2 Results Confirm Positive Thesis
-
Canaccord Genuity Raises Price Target on Equinix (EQIX); REIT Conversion Becoming Inevitable
-
Canaccord Genuity Remains Sidelined on Akamai Technologies (AKAM); Unexplained Swings in Revenue Not Reassuring
-
Canaccord Genuity Maintains a 'Buy' on Angie's List (ANGI); Continues On Track to Becoming Leading Local Marketplace
-
Canaccord Genuity Defends Intersil (ISIL); 5% Dividend Sets Floor

